Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

AU:MSB Stock Latest News

The FlyMesoblast announces changes, retirement of certain members of its Board47m agoMESO

Company AnnouncementsMesoblast Announces Board Changes Following Ryoncil Launch1h ago
Company AnnouncementsState Street Entities Exit Substantial Holder Position in Mesoblast6d ago
Company AnnouncementsMesoblast Sets Details for 2026 Annual General Meeting2w ago
Company AnnouncementsMesoblast Files Updated Corporate Governance Statement and ASX Appendix 4G2w ago

State Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold

Company AnnouncementsState Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold1M ago

The FlyMesoblast receives FDA approval for potency assay to release Ryoncil product1M agoMESO

Company AnnouncementsMesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches1M ago

Company AnnouncementsState Street Group Ceases to Be Substantial Holder in Mesoblast1M ago
The FlyMesoblast price target raised to $39 from $35 at Piper Sandler2M agoMESO
Company AnnouncementsMesoblast revenue surges on RYONCIL launch as late‑stage pipeline advances2M ago
Company AnnouncementsMesoblast Flags Risks Around 2026 Outlook and Stem Cell Strategy2M ago

Mesoblast Files 2026 Form 20-F, Affirms Status as Well-Known Issuer

Company AnnouncementsMesoblast Files 2026 Form 20-F, Affirms Status as Well-Known Issuer2M ago

The FlyLargest borrow rate increases among liquid names2M agoAZ HYG

Company AnnouncementsMesoblast Increases Director Philip Krause’s Equity-Based Incentives2M ago

Company AnnouncementsMesoblast Issues 875,000 Unquoted Employee Incentive Options2M ago
Company AnnouncementsMesoblast to Outline 2026 Results and Pipeline Progress in Investor Webcast2M ago
The FlyLargest borrow rate increases among liquid names2M agoV V
The FlyMesoblast completes patient treatment in MSB-DR004 in Phase 3 trial2M agoMESO

Mesoblast Reaches Pivotal Phase 3 Milestone in Chronic Back Pain Trial

Company AnnouncementsMesoblast Reaches Pivotal Phase 3 Milestone in Chronic Back Pain Trial2M ago

Company AnnouncementsState Street Group Ceases to Be Substantial Holder in Mesoblast2M ago

Company AnnouncementsState Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold3M ago